Cargando…
Metformin Use and Risk of All-Cause Mortality and Cardiovascular Events in Patients With Chronic Kidney Disease—A Systematic Review and Meta-Analysis
BACKGROUND: To evaluate whether metformin use assuredly alters overall all-cause death in patients with type 2 diabetes mellitus (T2DM) and chronic kidney disease (CKD). METHODS: Pubmed, Web of Science, Embase, and Cochrane Central Register of Controlled Trials were systematically searched from ince...
Autores principales: | Hu, Yao, Lei, Min, Ke, Guibao, Huang, Xin, Peng, Xuan, Zhong, Lihui, Fu, Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7575818/ https://www.ncbi.nlm.nih.gov/pubmed/33117278 http://dx.doi.org/10.3389/fendo.2020.559446 |
Ejemplares similares
-
FT3/FT4 ratio is correlated with all-cause mortality, cardiovascular mortality, and cardiovascular disease risk: NHANES 2007-2012
por: Lang, Xueyan, et al.
Publicado: (2022) -
Associations of serum alkaline phosphatase level with all-cause and cardiovascular mortality in the general population
por: Yan, Wei, et al.
Publicado: (2023) -
Body-Weight Fluctuation Was Associated With Increased Risk for Cardiovascular Disease, All-Cause and Cardiovascular Mortality: A Systematic Review and Meta-Analysis
por: Zou, Huajie, et al.
Publicado: (2019) -
Association between COVID-19 and incidence of cardiovascular disease and all-cause mortality among patients with diabetes
por: Jung, Hee Sun, et al.
Publicado: (2023) -
Obesity paradox and aging: Visceral Adiposity Index and all-cause mortality in older individuals: A prospective cohort study
por: Wang, Lei, et al.
Publicado: (2022)